Published by The Medical Letter, Inc. • 1000 Main Street, New Rochelle, N.Y. 10801 • A Nonprofit Publication

   options

 
The Medical Letter CME Program - The Medical Letter
The purpose of The Medical Letter Continuing Medical Education Program is to provide a means for health care professionals (primarily physicians and pharmacists) to keep up to date with new drugs that are approved by the FDA, as well as keep up with the standard of care treatments for specific indications.  Specifically, the content of The Medical Letter Continuing Medical Education Program covers the mechanisms of action, pharmacokinetics, clinical trials, adverse effects, interactions, dosages and routes of administration of the drugs discussed.  Participants are required to answer exam questions based on the content of The Medical Letter.  Importantly, the objectives of developing the content on which the exam is based are to educate the participant, impact clinical practice and improve patient outcomes.  The Medical Letter's unbiased content is free of commercial influence and financial sponsorship.  The Medical Letter does not accept advertising, grants or donations.  The program is completely funded by fees paid by the exam participants. The Medical Letter CME program is accredited by:  ACCME  AAFP  ACPE
Accreditation Information and Educational Objectives for Online Series Exams
Accreditation Information and Educational Objectives for Comprehensive Exams
Copyright and Privacy Statement
Frequently Asked Questions
Active Subscribers Enroll in Free Online Series
Enrolled already? Take your next exam in the series
Switch from Print Exam to Online Exam
Continue a purchased Comprehensive Online Exam
Order Treatment Guideline CME exams

You may earn up to 26 credits per year, by choosing one of the following:

Online Series – Freely available only to active subscribers of The Medical Letter. Answer six questions per issue and submit answers online. Earn one credit/exam.  Each online series contains 13 short exams. Already enrolled and need to take next exam? Click here.   1 credit/exam; 13 credits per series Enroll in Free Online Series

Comprehensive Exam –Available online or in print to Medical Letter subscribers, this 78 question test enables you to earn 13 AMA PRA Category 1 credits immediately with the successful completion of the test. Take the exam online and receive your CME certificate within 3 business days! Our Comprehensive exams allow you to test at your own pace in the comfort of your home or office. Save airfare, conference expenses and time away from your practice.  Comprehensive tests are offered every January and July enabling you to earn up to 26 credits per year.  $35.00/13 credits

Quick One-Credit Exam – Available to both subscribers and non-subscribers. Access content and answer six questions, online only, for any available issue and earn one credit.   1 credit/exam; $12.00/credit

NOTE: Credits earned on any individual exam can not be earned again on the comprehensive exam if it covers the same material. 26 credits are the maximum you can earn in any given year.
 
CME References
Exam #59 (January 2009)
Exam #60 (July 2009)
The Medical Letter Self-Examination

Domestic
& Foreign
(U.S.D.)
Comprehensive Online Exam —each exam eligible for 13 credits, 2 exams eligible for 26 total credits. Test at your own pace in the comfort of your home or office. Save airfare, conference expenses and time away from your practice.  Earn up to 13 credits immediately.

Exam #59 (based on issues July-December 2008)
Exam #60 (based on issues January-June 2009)
Exam #61 (based on issues July-December 2009)    Available January 15, 2010


each exam
Comprehensive Print Exam — each exam eligible for 13 credits, 2 exams eligible for 26 total credits:

Exam #59 (based on issues July-December 2008)
Exam #60 (based on issues January-June 2009) 
Exam #61 (based on issues July-December 2009)    Available January 15, 2010


each exam

Order postal copies of the 13 preceding issues
When ordering the CME comprehensive exam (print or online), issues published during the six-month period (13 issues) preceding each test may be ordered for $ .

Back issues for Exam #59
Back issues for Exam #60

Note: Institutional subscribers need not order these issues because they may be freely accessed in the online archives. Online exam customers will have online access to the articles during the test taking process.


Quick One-Credit Exam — Online Only 
I would like to order the following Online Per Issue Individual Exams eligible for 1 credit each:

1290 Lubiprostone (Amitiza) for Irritable Bowel Syndrome with Constipation; Wellbutrin Versus Generic Bupropion; The EarCheck Middle Ear Monitor for Detection of Middle Ear Effusion in Children   
1291 Duloxetine (Cymbalta) for Fibromyalgia; Drugs for Travelers' Diarrhea; ECGs Before Stimulants in Children   
1292 Antiplatelet Therapy for Patients with Stents; Methylnaltrexone (Relistor) for Opioid-Induced Constipation   
1293 Aliskiren/Hydrochlorothiazide (Tekturna HCT) for Hypertension; A New Rotavirus Vaccine; Ezetimibe Revisited   
1294 Monthly Risedronate (Actonel) for Postmenopausal Osteoporosis; Sunscreens: An Update   
1295 Clevidipine (Cleviprex) for IV Treatment of Severe Hypertension; Ciclesonide (Alvesco) — A New Inhaled Corticosteroid for Asthma   
1296 Influenza Vaccine 2008-2009; Dutasteride (Avodart) with Tamsulosin (Flomax) for Benign Prostatic Hyperplasia   
1297 Melamine; Certolizumab (Cimzia) for Crohn’s Disease; Drug Interactions with Simvastatin   
1298 Prostate Cancer Screening; Prevention of Venous Thromboembolism in Orthopedic Surgery   
1299 Advertisements for TNF Inhibitors; Safety of SSRIs in Pregnancy; Bendamustine (Treanda) for CLL and NHL   
1300 Fluoroquinolones and Tendon Injuries; Alvimopan (Entereg) for Postoperative Ileus; CT Colonography (Virtual Colonoscopy) Revisited   
1301 CRP and Statins for Primary Prevention of Coronary Artery Disease; Antiviral Drugs for Influenza   
1302 Drugs That May Cause Psychiatric Symptoms; A Granisetron Patch (Sancuso)   
1303 Long-Acting Beta-2 Agonists in Asthma; PPI Interactions with Clopidogrel; Silodosin (Rapaflo) for Benign Prostatic Hyperplasia   
1304 More Resistance to Oseltamivir (Tamiflu); Implantable Cardioverter Defibrillators; Tetrabenazine (Xenazine) for Huntington's Chorea
1305 A Diuretic for Initial Treatment of Hypertension?; Two New Drugs for Chronic ITP; Repetitive Transcranial Magnetic Stimulation (TMS) for Medication-Resistant Depression   
1306 PPI Interactions with Clopidogrel Revisted, Conjugated Estrogens (Premarin) Vaginal Cream, Screening for Oral Cancer   
1307 Extended-Release Amoxicillin for Strep Throat; Alemtuzumab (Campath) Off-Label for Relapsing Multiple Sclerosis; Rufinamide (Banzel) for Epilepsy   
1308 Dexlansoprazole (Kapidex) for GERD and Erosive Esophagitis; Focalin XR for ADHD   
1309 Vancomycin Dosing and Monitoring; Deep Brain Stimulation for Parkinson's Disease; Valproic Acid Delayed Release (Stavzor)
1310 Azelastine (Astepro) Nasal Spray for Allergic Rhinitis; Adapalene-Benzoyl Peroxide (Epiduo) for Acne  
1311 Fenofibric Acid (Trilipix); Fesoterodine (Toviaz) for Overactive Bladder; Drugs for MRSA with Reduced Susceptibility to Vancomycin 
1312 Febuxostat (Uloric) for Chronic Treatment of Gout; Encapsulated Mesalamine Granules (Apriso) for Ulcerative Colitis; Colon Cleansing 
1313  Metformin/Repaglinide (PrandiMet) for Type 2 Diabetes; Bimatoprost 0.03% Solution (Latisse) for Eyelash Enhancement 
1314  Milnacipran (Savella) for Fibromyalgia; Exforge HCT; Pneumococcal Vaccination of Adults: Polysaccharide or Conjugate?   
1315  Biennial IV Zoledronic Acid (Reclast) for Prevention of Osteoporosis; A Medical Food for Alzheimer's Disease; Lacosamide for Epilepsy   
1316  Acetaminophen Safety - Déjà Vu; Golimumab (Simponi) for Inflammatory Arthritis   
1317  Propylthiouracil for Hyperthyroidism; Benzyl Alcohol Lotion for Head Lice; When a Statin Fails   
1318  Tapentadol (Nucynta) - A New Analgesic; Tablet Splitting; Heat and Transdermal Fentanyl   
1319  Safety of Smoking Cessation Drugs; A New Japanese Encephalitis Vaccine (Ixiaro); Insulin Glargine (Lantus) and Cancer Risk   
1320  Prasugrel (Effient) vs. Clopidogrel (Plavix); Calcitriol (Vectical) for Mild to Moderate Plaque Psoriasis; Red Yeast Rice   
1321  Seasonal Trivalent Influenza Vaccine for 2009-2010; Resveratrol; Artemether-Lumefantrine (Coartem) for Treatment of Malaria   
1322  H1N1 Vaccine for Prevention of Pandemic Influenza; Dronedarone (Multaq) for Atrial Fibrillation   
1323  Generic Drugs Revisited; Degarelix (Firmagon) for Prostate Cancer; Recombinant Human Antithrombin (ATryn)   
1324  Saxagliptin (Onglyza) for Type 2 Diabetes; Tadalafil (Adcirca) for Pulmonary Arterial Hypertension   
1325  Antiviral Drugs for Influenza   Available 11/13/09

$12
per credit
 
          
Show my current order
 

 
© 2009 The Medical Letter, Inc. All rights reserved. Use of this site signifies your agreement to the Terms and Conditions.